Article info
PDFBiochemical genetics
Original research
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
- Correspondence to Dr Christiane Auray-Blais, Pediatrics, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; christiane.auray-blais{at}usherbrooke.ca
Citation
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
Publication history
- Received May 4, 2020
- Revised July 14, 2020
- Accepted August 3, 2020
- First published September 22, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.